Drug Shortage Report for UROMITEXAN
Report ID | 203947 |
Drug Identification Number | 02371839 |
Brand name | UROMITEXAN |
Common or Proper name | Mesna Injection |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | MESNA |
Strength(s) | 100MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1 gram (2639B3923) |
ATC code | V03AF |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2023-09-08 |
Actual start date | 2023-09-08 |
Estimated end date | 2023-09-22 |
Actual end date | 2023-09-26 |
Shortage status | Resolved |
Updated date | 2023-09-27 |
Company comments | Product is on 0% allocation – demand increase due to covering for FK’s backorder |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2023-09-27 | English | Compare |
v7 | 2023-09-26 | French | Compare |
v6 | 2023-09-26 | English | Compare |
v5 | 2023-09-26 | French | Compare |
v4 | 2023-09-26 | English | Compare |
v3 | 2023-09-09 | English | Compare |
v2 | 2023-09-08 | French | Compare |
v1 | 2023-09-08 | English | Compare |
Showing 1 to 8 of 8